ORI
"ORI" is a word mark owned by Oribiotech Limited, filed at the USPTO on June 7, 2021. It is registered and covers classes 9 and 42.
- Status
- Registered
- Since July 25, 2023
- Filed
- June 7, 2021
- Registered
- July 25, 2023
- Priority date
- June 1, 2021
- Claimed from United Kingdom
- Application no.
- 90757832
- Registration no.
- 7117661
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns ORI
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Oribiotech Limited
London, United Kingdom
Representative
Howard J Shire
Troutman Pepper Locke LLP
What the mark covers
The products and services ORI is filed for, grouped by Nice class.
downloadable computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy, and gene therapy; downloadable computer software platforms for monitoring environmental conditions within buildings, apparatuses and equipment, and for controlling, programming and adjusting devices within a building, facility, grounds, and designated spatial area that control environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for collecting and storing data in the fields of cell culturing, cell therapy and gene therapy; downloadable computer software platforms for monitoring patient health, downloadable computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy
Software as a service (SaaS) services featuring software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culture, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for controlling, monitoring, programming, communicating with, operating and adjusting apparatus and equipment in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for monitoring environmental conditions within cell culturing containers and bioreactors and controlling, programming and adjusting devices within a cell culturing container, bioreactor and designated spatial area that controls environmental conditions, in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SAAS) services featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring software for collecting and storing of data in the fields of cell culturing, cell therapy and gene therapy; Software as a service (SaaS) services featuring software for monitoring patient health; Software as a service (SaaS) services featuring software for providing information in the fields of cell culture, cell therapy and gene therapy; Providing temporary use of on-line non-downloadable computer software for providing information in the fields of cell culturing, cell therapy and gene therapy; Platform as a service (PAAS) featuring computer software platforms for providing information in the fields of cell culturing, cell therapy and gene therapy; design and development of scientific equipment and apparatus in the fields of cell culturing, cell therapy and gene therapy; design and development of cell culturing, cell therapy and gene therapy manufacturing equipment, manufacturing systems and manufacturing processes for others; development of cell culturing, cell therapy and gene therapy processes for others; rental and leasing of scientific apparatus and equipment for cell culturing, cell therapy and gene therapy
What has happened so far
Steps recorded by the USPTO, newest first.
- Teas change of correspondence received
- Teas change of domestic representatives address
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Teas change of correspondence received
- Teas change of domestic representatives address
- Attorney/dom.rep.revoked and/or appointed
- Teas revoke/app/change addr of atty/dom rep received
- Applicant/correspondence changes (non-responsive) entered
- Teas change of owner address received
10 earlier steps on the official record.
About ORI
Who owns the trademark "ORI"?
The USPTO trademark "ORI" (application 90757832) is owned by Oribiotech Limited.
What is the status of "ORI"?
Its status at the USPTO is: registered.
When was "ORI" registered?
It was registered on July 25, 2023.
Get this data via the API
Everything on this page comes from the Signa API. Pull ORI and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2d67-3949-7738-aa68-965d1ba2db2d
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2d67-3949-7738-aa68-965d1ba2db2d",
"object": "trademark",
"mark_text": "ORI",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "90757832",
"filing_date": "2021-06-07",
"nice_classes": [
9,
42
],
"owners": [
{
"name": "Oribiotech Limited",
"entity_id": "ent_019eb70d-9fe3-736f-8562-592ee4425a64"
}
]
}